Arbutus Biopharma Corpora... (ABUS)
NASDAQ: ABUS
· Real-Time Price · USD
3.33
-0.18 (-5.13%)
At close: May 06, 2025, 3:59 PM
3.37
1.05%
After-hours: May 06, 2025, 06:06 PM EDT
13F Institute Ownership
Total Institutes of 163 in Arbutus Biopharma expanded their positions with an increase of 9 investors compared to the previous quarter. An additional 2.98M shares, as total invested capital declined by $48.04M with ownership percentage increasing from 53.46% to 55.04%.
Options Activity
Institutions are holding Calls/Puts contracts nearly balanced, indicating a neutral sentiment.
Put/Call 1.026
1.03
Call Flow 649,100
49%
Put Flow 666,100
51%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Morgan Stanley | 11.95% | 22.59M | +4.05% | 73.86M | < 0.01% |
| Whitefort Capital Management, ... | 7.01% | 13.24M | +2.91% | 43.3M | 20.72% |
| Blackrock, Inc. | 6.85% | 12.94M | +5.88% | 42.31M | < 0.01% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.